Molecular mechanisms of endometrial progesterone resistance
子宫内膜黄体酮抵抗的分子机制
基本信息
- 批准号:10393011
- 负责人:
- 金额:$ 4.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-15 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:AblationAnimal ModelBiological ModelsCXCL9 geneCenters for Disease Control and Prevention (U.S.)CouplesDefectDevelopmentDiagnosisDiseaseERBB2 geneEndometrialEndometrial Stromal CellEndometriumEpithelialEstrogensEtiologyFemaleFemale infertilityFunctional disorderGenesGenetic ModelsGenetically Engineered MouseHumanImaging TechniquesImpairmentInfertilityKnock-outMediatingMediator of activation proteinMitogensMolecularMorphologyMusPhenotypePregnancyProblem SolvingProgesteroneProgesterone ReceptorsProto-OncogenesRegulationResistanceRoleSignal PathwaySignal TransductionSpontaneous abortionSpousesTestingTissuesUterusWomanWomen&aposs HealthWorkage groupagedbiomedical imagingcostearly pregnancy lossendometriosis-related infertilityexperimental studyfailure Implantationhormone regulationimplantationinfertility treatmentmouse modelmyometriumnatural Blastocyst Implantationoverexpressionpopulation basedpregnancy failurepregnantreproductivereproductive tractresponsesuccesstrying to conceiveuterine receptivity
项目摘要
Project Summary
The Centers for Disease Control and Prevention has estimated that there are approximately 6.1 million infertile
couples with a female spouse aged 15-44 in the U.S., which is about 6.7% of the domestic married couple
population base for that age group. Miscarriage before 20 weeks also occurs in about 15% of known
pregnancies, and over 75% of failed pregnancies involve implantation defects. To solve these problems, we
must understand the mechanisms of uterine receptivity and implantation to develop better treatments that may
be currently out of reach. The endometrium's epithelial and stromal compartments undergo dynamic molecular
and morphological changes to prepare for implantation and development. Endometrial P4 resistance implies a
decreased responsiveness of target tissue to bioavailable P4, and such an impaired P4 response is seen in the
endometrium of women with non-receptive endometrium. However, exactly how P4 signaling becomes
defective in a non-receptive endometrium is still unclear. MIG-6 acts as a key P4 signaling mediator to inhibit
E2-mediated epithelial proliferation in the endometrium of the human and mouse. We hypothesize that Mig-6
loss causes endometrial P4 resistance by ErbB2 overexpression in the endometrium and by dysregulating P4
signaling in endometrial stromal cells. In this proposal, our objective is to determine how MIG-6 functions in the
uterus and how it is dysregulated in endometrial P4 resistance and infertility. Our Specific Aims are directed at
understanding: 1) the pathophysiological role of MIG-6 loss in implantation failure; and 2) the effect of Erbb2
ablation on female infertility with Mig-6 deficiency. Using our mouse models and biomedical imaging
techniques, we will determine the role of Mig-6 loss in implantation failure and test Erbb2 targeting to treat
endometrial P4 resistance and restore implantation. Our results will enhance our understanding of reproductive
pathophysiology as well as enable the development of more effective strategies for the diagnosis and
treatment of infertility.
项目摘要
疾病控制和预防中心估计,大约有610万不孕症患者,
在美国有15-44岁女性配偶的夫妇,这一比例约为6.7%,
这个年龄段的人口基数。20周前流产也发生在约15%的已知
怀孕,超过75%的失败怀孕涉及植入缺陷。为了解决这些问题,我们
必须了解子宫容受性和着床的机制,以开发更好的治疗方法,
目前无法触及。子宫内膜的上皮和间质区室经历动态的分子调控,
和形态变化,为植入和发育做准备。子宫内膜P4抵抗意味着
靶组织对生物可利用的P4的反应性降低,并且这种受损的P4反应见于
非接受性子宫内膜妇女的子宫内膜。然而,P4信号是如何变成
非接受性子宫内膜的缺陷仍不清楚。β 2 -6作为一个关键的P4信号介质,抑制
E2介导的人和小鼠子宫内膜上皮细胞增殖。我们假设米格-6
ErbB 2在子宫内膜过度表达和P4失调导致子宫内膜P4抵抗
子宫内膜间质细胞中的信号传导。在本提案中,我们的目标是确定在全球范围内,
子宫及其在子宫内膜P4抵抗和不孕症中的失调。我们的具体目标是针对
理解:1)Erbb 2 -6缺失在着床失败中的病理生理作用; 2)Erbb 2
治疗Mig-6缺乏性女性不孕症使用我们的小鼠模型和生物医学成像
技术,我们将确定Mig-6丢失在植入失败中的作用,并测试Erbb 2靶向治疗
子宫内膜P4抵抗和恢复种植。我们的研究结果将增强我们对生殖的理解,
病理生理学,以及使发展更有效的战略,诊断和
治疗不孕症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jae-Wook Jeong其他文献
Jae-Wook Jeong的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jae-Wook Jeong', 18)}}的其他基金
The role of cholesterol biosynthesis in metastatic and recurrent endometrialcancer
胆固醇生物合成在转移性和复发性子宫内膜癌中的作用
- 批准号:
10560609 - 财政年份:2022
- 资助金额:
$ 4.52万 - 项目类别:
Molecular mechanisms of endometrial progesterone resistance
子宫内膜黄体酮抵抗的分子机制
- 批准号:
10618181 - 财政年份:2022
- 资助金额:
$ 4.52万 - 项目类别:
Development of anti-inflammatory nanodrug for endometriosis treatment
开发治疗子宫内膜异位症的抗炎纳米药物
- 批准号:
10709492 - 财政年份:2022
- 资助金额:
$ 4.52万 - 项目类别:
The role of cholesterol biosynthesis in metastatic and recurrent endometrial cancer
胆固醇生物合成在转移性和复发性子宫内膜癌中的作用
- 批准号:
10467152 - 财政年份:2022
- 资助金额:
$ 4.52万 - 项目类别:
The role of cholesterol biosynthesis in metastatic and recurrent endometrialcancer
胆固醇生物合成在转移性和复发性子宫内膜癌中的作用
- 批准号:
10661912 - 财政年份:2022
- 资助金额:
$ 4.52万 - 项目类别:
Epigenetic regulation of receptive endometrium
容受性子宫内膜的表观遗传调控
- 批准号:
10674101 - 财政年份:2022
- 资助金额:
$ 4.52万 - 项目类别:
Epigenetic regulation of receptive endometrium
容受性子宫内膜的表观遗传调控
- 批准号:
10551346 - 财政年份:2022
- 资助金额:
$ 4.52万 - 项目类别:
Molecular mechanisms of endometrial progesterone resistance
子宫内膜黄体酮抵抗的分子机制
- 批准号:
10662676 - 财政年份:2022
- 资助金额:
$ 4.52万 - 项目类别:
Epigenetic regulation of receptive endometrium
容受性子宫内膜的表观遗传调控
- 批准号:
10390408 - 财政年份:2021
- 资助金额:
$ 4.52万 - 项目类别:
SIRT1 as a Therapeutic Target in Endometriosis
SIRT1 作为子宫内膜异位症的治疗靶点
- 批准号:
10309093 - 财政年份:2021
- 资助金额:
$ 4.52万 - 项目类别:
相似海外基金
Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
- 批准号:
495434 - 财政年份:2023
- 资助金额:
$ 4.52万 - 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
- 批准号:
10586596 - 财政年份:2023
- 资助金额:
$ 4.52万 - 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
- 批准号:
10590479 - 财政年份:2023
- 资助金额:
$ 4.52万 - 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:
10642519 - 财政年份:2023
- 资助金额:
$ 4.52万 - 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
- 批准号:
23K06011 - 财政年份:2023
- 资助金额:
$ 4.52万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
- 批准号:
10682117 - 财政年份:2023
- 资助金额:
$ 4.52万 - 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
- 批准号:
10708517 - 财政年份:2023
- 资助金额:
$ 4.52万 - 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
- 批准号:
10575566 - 财政年份:2023
- 资助金额:
$ 4.52万 - 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
- 批准号:
23K15696 - 财政年份:2023
- 资助金额:
$ 4.52万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
- 批准号:
23K15867 - 财政年份:2023
- 资助金额:
$ 4.52万 - 项目类别:
Grant-in-Aid for Early-Career Scientists